Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma

Nature Reviews Clinical Oncology

Volumn 6, Issue 5, 2009, Pages 251-253

  DuBois, Steven G ^a   Grier, Holcombe E ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EVENT FREE SURVIVAL; EWING SARCOMA; HUMAN; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MUCOSA INFLAMMATION; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TUMOR LOCALIZATION; TUMOR VOLUME; DISEASE FREE SURVIVAL; DRUG EFFECT; FOLLOW UP; METASTASIS; NOTE; PATHOLOGY; RADIOGRAPHY; TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; NEOPLASM METASTASIS; SARCOMA, EWING'S; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; VINCRISTINE;

EID: 67651222778     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2009.25     Document Type: Article

References (7)

1. Paulussen, M. et al. Results of the EICESS-92 Study: Two randomized trials of Ewing's sarcoma treatment - cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J. Clin. Oncol. 26, 4385-4393 (2008).
2. Magrath, i. et al. A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people. Cancer Chemother. Pharmacol. 18, S25-S28 (1986).
3. Miser, J. S. et al. Ifosfamide with mesna uroprotection and etoposide: An effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J. Clin. Oncol. 5, 1191-1198 (1987).
4. Oberlin, O. et al. No benefit of ifosfamide in Ewing's sarcoma: A nonrandomized study of the French society of Pediatric Oncology. J. Clin. Oncol. 10, 1407-1412 (1992).
5. Craft, A. et al. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The second United Kingdom Children's Cancer study Group and the Medical Research Council Ewing's Tumor study. J. Clin. Oncol. 16, 3628-3633 (1998).
6. Paulussen, M. et al. Localized Ewing tumor of bone: Final results of the cooperative Ewing's Sarcoma Study CESS 86. J. Clin. Oncol. 19, 1818-1829 (2001).
7. Grier, H. E. et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N. Engl. J. Med. 348, 694-701 (2003).